Acute GVH disease
Information
- Disease name
- Acute GVH disease
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT04960644 | Active, not recruiting | Phase 3 | MTX and Steroid as First-line Therapy for aGVHD | June 25, 2021 | December 31, 2022 |
| NCT02641236 | Completed | Phase 2 | Gut Decontamination In Pediatric Allogeneic Hematopoietic | March 2016 | October 28, 2021 |
| NCT03320928 | Completed | Skin Disease and Pulmonary Mortality After Transplantation | October 21, 2016 | November 24, 2016 | |
| NCT01485055 | Terminated | Phase 2 | Infliximab and Basiliximab for Treatment of Steroid Refractory Acute Graft Versus Host Disease | December 2011 | September 26, 2016 |
| NCT02254798 | Unknown status | Biomarkers for Acute Graft-versus-host Disease | January 2014 | December 2017 | |
| NCT01589549 | Unknown status | Phase 2 | Mesenchymal Stromal Cells for Acute Graft Versus Host Disease | April 2012 | December 2016 |
| NCT04677868 | Unknown status | Phase 2 | MTX and Steroid for aGVHD Treatment | December 23, 2020 | June 2022 |
| NCT01754454 | Unknown status | Phase 1/Phase 2 | Safety and Efficacy of UC-MSC in Patients With Acute Severe Graft-versus-host Disease | December 2012 | December 2016 |
| NCT02917148 | Withdrawn | MicroRNAs as Diagnostic and Predictive Biomarkers for Acute Graft Versus Host Disease | September 2016 | September 2018 |